Neoadjuvant chemotherapy: Not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast?

Arnie Purushotham, Sarah Pinder, Massi Cariati, Mark Harries, Aron Goldhirsch

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)3552-3554
Number of pages3
JournalJournal of Clinical Oncology
Volume28
Issue number22
DOIs
Publication statusPublished - Aug 1 2010

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this